Sugi Predict

Sugi Predict / Compounds / SCHEMBL31672269

SCHEMBL31672269

SCHEMBL31672269

CSCC[C@H](NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)CNC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.58

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ APLNR P35414 2/20 0.58
▸ CALCR P30988 4/20 0.56
▸ KDM1A O60341 2/20 0.53
▸ MC4R P32245 1/20 0.52
▸ GLP1R P43220 3/20 0.51
▸ GCGR P47871 3/20 0.51
▸ TFPI P10646 1/20 0.51
▸ F2 P00734 2/20 0.51
▸ CRHR1 P34998 1/20 0.51
▸ CRHR2 Q13324 1/20 0.51
▸ NMUR2 Q9GZQ4 1/20 0.50
▸ NMUR1 Q9HB89 1/20 0.50
▸ PTH1R Q03431 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30612516 0.88 APLNR (0.55) APLNRCALCRGLP1RGCGRTFPI
SCHEMBL6437072 0.88 CALCR (0.63) APLNRCALCRPTH1R
SCHEMBL29575208 0.88 CALCR (0.74) APLNRCALCRGLP1RF2CRHR1
SCHEMBL31182575 0.85 TFPI (0.63) CALCRGLP1RGCGRTFPI
SCHEMBL31127551 0.84 CALCR (0.67) CALCRGLP1RGCGRTFPICRHR1
SCHEMBL31182727 0.84 KDM1A (0.65) CALCRKDM1ATFPIF2NMUR2
SCHEMBL31182574 0.84 CALCR (0.63) APLNRCALCRKDM1A
SCHEMBL30710166 0.83 APLNR (0.45) APLNRCALCRMC4RCRHR1CRHR2
SCHEMBL31182818 0.83 CALCR (0.63) CALCRGLP1RGCGR
SCHEMBL30567739 0.83 TFPI (0.56) APLNRCALCRMC4RGLP1RGCGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12383608-B2 WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides Sumitomo Pharma Co., Ltd. (JP) 2025-08-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12383608-B2 WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides KLK3, TAP1, KLHL6 APLNR 356/4885CALCR 2521/4885KDM1A 3768/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback